Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03293069
What this trial is testing

Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Lille 372
Not applicableLooking for participantsNCT00912041
What this trial is testing

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Who this might be right for
TetraplegiaSpinal Cord InjuriesAmyotrophic Lateral Sclerosis+3 more
Leigh R. Hochberg, MD, PhD. 27
Early research (Phase 1)Study completedNCT06676423
What this trial is testing

Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Corestemchemon, Inc. 8
Not applicableUnknownNCT04686110
What this trial is testing

Analysis of Capillary Retinal and Papillary Vascularization in Patients With Amyotrophic Lateral Sclerosis - CAPISLA

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Angers 94
Not applicableStudy completedNCT03154450
What this trial is testing

EncoreAnywhere Use in Motor Neurone Disease

Who this might be right for
Motor Neuron Disease
Sheffield Teaching Hospitals NHS Foundation Trust 19
Testing effectiveness (Phase 2)Study completedNCT01551940
What this trial is testing

Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea

Who this might be right for
SialorrheaAmyotrophic Lateral Sclerosis
Hospices Civils de Lyon 18
Early research (Phase 1)Looking for participantsNCT07571174
What this trial is testing

A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Eli Lilly and Company 32
Not applicableStudy completedNCT01641965
What this trial is testing

Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Hospital Universitari de Bellvitge 42
Testing effectiveness (Phase 2)Study completedNCT01806857
What this trial is testing

Clinical Trial Nuedexta in Subjects With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Center for Neurologic Study, La Jolla, California, 90
Testing effectiveness (Phase 2)Looking for participantsNCT07414212
What this trial is testing

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogipuzkoa Health Research Institute 90
Early research (Phase 1)Looking for participantsNCT06671236
What this trial is testing

Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Novabio Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT05039099
What this trial is testing

Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
AL-S Pharma 73
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Early research (Phase 1)Study completedNCT03487263
What this trial is testing

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

Who this might be right for
Motor Neuron DiseaseAmyotrophic Lateral Sclerosis
Implicit Bioscience 10
Not applicableUnknownNCT02874209
What this trial is testing

Noninvasive Assessment of Neuronal Damage by MRI Sodium ( 23Na ) in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique Hopitaux De Marseille 60
Not applicableUnknownNCT04393467
What this trial is testing

Transcranial Static Magnetic Field Stimulation (tSMS) in Amyotrophic Lateral Sclerosis (ALS).

Who this might be right for
Amyotrophic Lateral Sclerosis
Campus Bio-Medico University 40
Not applicableWithdrawnNCT05041114
What this trial is testing

SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

Who this might be right for
Neurologic DisorderParalysisParalysis; Stroke+7 more
Synchron Medical, Inc.
Not applicableStudy completedNCT00334516
What this trial is testing

Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis

Who this might be right for
Cerebral Cortex Dysfunction
National Institute of Neurological Disorders and Stroke (NINDS) 77
Testing effectiveness (Phase 2)Ended earlyNCT06910384
What this trial is testing

STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
New England Cell Therapeutics, Inc. 1
Not applicableLooking for participantsNCT06668649
What this trial is testing

Polish Version Fatigue Severity Scale

Who this might be right for
Multiple SclerosisAmyotrophic Lateral SclerosisStroke, Ischemic
Jakub Antczak 310
Next Page